If emerging markets are not already a core part of your portfolio, you may be missing out on what one analyst declares will be “the global growth powerhouse over the next 10 years” – not the developed economies of the U.S. or Europe, but rather the likes of Vietnam, Indonesia and others. For more on why “emerging markets have to be a core part of your portfolio” – and the risks that accompany the opportunities that emerging markets present, CLICK HERE.
When is a dividend stock that the market is especially bearish on a deep value buying opportunity and when is it a yield/value trap? The Deep Value Dividend Growth Portfolio managed by the author of today’s article “is all about investing in quality dividend payers, at good to great prices, opportunistically when the market becomes extremely bearish on quality income producing assets” – and it recently added three stocks that are available at deep discounts, sport attractive yields and offer 18%+ long-term return potential. For more,CLICK HERE.
“The dividend aristocrats index tends to shine during bear markets and low return environments. However, it also pulls its weight when we are in a bull market too. It is the best of both worlds really,” notes the author of today’s article, who proceeds to identify the 57 companies that make up the Dividend Aristocrats index for 2019 – and which may serve as a list of stocks for further research and consideration. For these stocks – including the four new additions to the index – CLICK HERE.
How did a self-made Brazilian billionaire lose his $35 billion empire practically overnight? The author of today’s article points to a lesson that he advises investors need to be aware of: “The portfolio that helps you get rich isn’t necessarily the portfolio that’s going to help you remain rich.” So, if you’re an investor that has amassed significant wealth, how can you go about engineering a portfolio that will help you keep (and ideally continue to grow) that wealth? The author shows why this is more difficult than many think – and outlines what may be the best strategy. CLICK HERE.
While the revolution from traditional retail to online retail has been underway for quite some time in developed markets, emerging markets are now seeing significant increases in e-commerce sales – and there’s a new ETF available to investors looking to tap into this momentum. For more on this ETF, which has an exclusive focus on international online retailing and which today’s article declares “should see uninterrupted success”, CLICK HERE.
“New traders are often seduced by the patterns of indicators, but this work invariably ends in disappointment when results don’t follow,” notes the author of today’s article. Given this, he proceeds to outline what may be a better approach to getting started in technical analysis. For this approach (the principles of which even more experienced traders can still benefit from) and some of the “pitfalls” of traditional technical analysis, CLICK HERE.
Gossamer Bio is a San Diego-based biotech that is readying for an initial public offering – and with a diverse pipeline including potential treatments for a severe type of asthma, pulmonary arterial hypertension and inflammatory bowel disease, this IPO could be particularly appealing to investors. However, despite the promise associated with this biotech, there are also a number of potential problems that prospective investors should be aware of. For more, CLICK HERE.
After experiencing a rough 2018, today’s article notes that “the investment case for emerging markets has vastly improved” – and highlights some specific emerging market recommendations from some big-name investors. Among these recommendations is an Eastern European bank which one equity research firm notes “ranks first as the most undervalued name with outstanding profitability… and one of the highest dividend yields in the sector”. For more, CLICK HERE.
“This could be gold’s year,” declares one precious metals analyst cited in today’s article on how the yellow metal, the price of which has been hitting eight-month highs, could flirt with the $1,400 per ounce price level by the end of this year – a level it has not touched since 2013. For more on the confluence of factors that has led to a changing demand dynamic – and prospects – for gold this year, CLICK HERE.
It’s probably not a surprise to learn that the stocks that were the most adored by analysts at the start of 2018 beat the overall market last year. A little more surprising, however, is the fact that the stocks that were the most despised by analysts at the start of last year also ended up beating the market. Given this, which stocks are the biggest analyst darlings (and which stocks are the most disliked by analysts) as 2019 gets underway – and which group (the adored or the despised) might end up doing better this year? CLICK HERE.